(2006). al: Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: a case-control study in East Asia.
(2004). Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol
(2006). Aozasa K: Epidemiology and pathologic features of Hodgkin lymphoma.
(2009). C: Clinicopathologic characteristics of T-cell non-Hodgkin’s lymphoma: a single institution experience.
(2006). Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
(2004). Clinicopathological Features of Extranodal Lymphomas: Kuwait Experience. Oncology
(2007). Coiffier B: Lymphoma in older patients.
(2005). CR: Distribution and ZAP-70 Expression of WHO Lymphoma Categories in Shanxi, China: A Review of 447 Cases Using a Tissue Microarray Technique.
(1998). DD: Epidemiology of the nonHodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol
(2010). Diffuse Large B-Cell Lymphoma in Chinese Patients: Immunophenotypic and Cytogenetic Analyses of 124 Cases.
(2010). Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification.
(2011). E, et al: Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab.
(2004). E: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood
(2008). E: Extranodal Lymphomas: Pathology and Management London: Informa Healthcare;
(1998). Epstein-Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis. Leukemia
(2009). et al: A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy. Clin Cancer Res
(2005). et al: Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol
(2008). et al: Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to
(2000). et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature
(2008). et al: Extranodal non-Hodgkin’s lymphomas–a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin’s lymphomas. Asian Pac J Cancer Prev
(2009). et al: Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol
(2002). et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
(2005). Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia. Br J Haematol
(2008). International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Irons RD: A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai,
(2009). Lim ST: Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit
(2009). MS: Adolescent nonHodgkin lymphoma and Hodgkin lymphoma: state of the science.
(1992). MS: Lymphoma incidence patterns by WHO subtype in the United States,
(2008). Ohshima K: Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006. Pathol Int
(2003). Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol
(1997). Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol
(1999). Primary extranodal non-Hodgkin’s lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol
(2006). The clinical and pathological analysis for 1125 cases with non-Hodgkin’s lymphoma. Ai Zheng Jin Zhan
(2010). The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol
(1997). The Non-Hodgkin’s Lymphoma Classification Project: Effect of age on the characteristics and clinical behavior of non-Hodgkin’s lymphoma patients. Ann Oncol
Vardiman JW: WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues
(2008). Vardiman JW: WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues Lyon: IARC;
(2006). WQ: A Report
(2008). Yang W-I: Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.
(2005). ZC: Clinical and pathological reassessment of 493 cases of non-Hodgkin’s lymphomas according to current WHO classification of lymphoid neoplasms. Zhong Hua Bing Li Xue Za Zhi
(2009). Zhang GQ: The Clinical and Pathological Analysis of 1,012 Cases of Non-Hodgkins Lymphoma. Zhong Guo Zhong Liu Lin Chuang